These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17957)

  • 1. [The problems of adverse effects to the liver of alpha-methyldopa].
    Zenos A
    Z Gesamte Inn Med; 1977 Apr; 32(7):168-71. PubMed ID: 17957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease.
    Fernández-Miranda C; Pérez-Carreras M; Colina F; López-Alonso G; Vargas C; Solís-Herruzo JA
    Dig Liver Dis; 2008 Mar; 40(3):200-5. PubMed ID: 18261709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of hypertension with methyldopa. IV. Duration of methyldopa therapy.
    del Greco F; Huang CM; Quintanilla A
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S99-103. PubMed ID: 6172673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
    Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
    Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
    Papatheodoridis GV; Goulis J; Christodoulou D; Manolakopoulos S; Raptopoulou M; Andrioti E; Alexandropoulos N; Savvidou S; Papachristou A; Zervou E; Seferiadis K; Kousidou P; Vogiatzakis E; Tsianos E
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):281-7. PubMed ID: 17353691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative study of nisoldipine and alpha-methyldopa in aged patients with isolated systolic hypertension].
    Guillén Llera F; Reuss JM; Sagués F; Tobares N
    Rev Clin Esp; 1991 Dec; 189(9):412-5. PubMed ID: 1792369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of gamma-glutamyl transpeptidase in the preoperative metastatic evaluation of renal cell carcinoma.
    Sandock DS; Seftel AD; Resnick MI
    J Urol; 1997 Mar; 157(3):798-9. PubMed ID: 9072569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver.
    Loguercio C; De Simone T; D'Auria MV; de Sio I; Federico A; Tuccillo C; Abbatecola AM; Del Vecchio Blanco C;
    Dig Liver Dis; 2004 Jun; 36(6):398-405. PubMed ID: 15248380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive activity of alpha-methyldopa on a twice daily regimen in comparison to metoprolol. A multi-centre controlled clinical trial.
    Muiesan G; Agabiti-Rosei E; Alicandri C; Motolese M
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():35-41. PubMed ID: 354827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-methyldopa and drug fever. A study of the metabolism of alpha-methyldopa in patients and normal subjects.
    Valnes K; Hillestad L; Hansen T; Arnold E
    Acta Med Scand; 1978; 204(1-2):21-5. PubMed ID: 685725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe hypertension with Catapres (St 155). A comparative study of the effect of catapres and methyldopa in a series of hypertensive outpatients (WHO stage 3).
    Becker-Christensen F; Bang HO; Ditzel J
    Acta Med Scand; 1971; 190(1-2):21-6. PubMed ID: 5099124
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study.
    Atasoy N; Erdogan A; Yalug I; Ozturk U; Konuk N; Atik L; Ustundag Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1255-60. PubMed ID: 17600607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of hypertension with methyldopa. III. Tolerability.
    Caldwell JR; Metts JC
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S92-8. PubMed ID: 6172672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of hypertension with methyldopa. VIII. Overview.
    Itskovitz HD
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S120-7. PubMed ID: 6172668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
    Al-Damluji SF; Al-Khalidi A; Shaarbaf H; Tawfiq NH
    Pharmatherapeutica; 1982; 3(2):133-9. PubMed ID: 7048338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum gamma-glutamyl transpeptidase: its clinical significance.
    Pár A; Mestyán I; Kádas I; Balázs M; Gógl A
    Acta Med Acad Sci Hung; 1976; 33(4):309-19. PubMed ID: 23644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of debrisoquine and methyldopa in hypertension.
    Pörsti P
    Ann Clin Res; 1976 Feb; 8(1):55-62. PubMed ID: 779588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.
    Huang MJ; Li KL; Wei JS; Wu SS; Fan KD; Liaw YF
    Am J Gastroenterol; 1994 Jul; 89(7):1071-6. PubMed ID: 7912472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.